The European Drug–Drug Interaction (EuroDDI) Study Protocol: A Cross‐Country Comparison of Drug–Drug Interaction Prevalence in the Older Community‐Dwelling Population

Documenti analoghi

• The Prevalent New‐User Design to Study Drug–Drug Interactions: The Example of Sulfonylureas and Warfarin Interaction on the Risk of Severe Hypoglycemia
  di: Wanqi Wang, et al.
  Pubblicazione: (2024)
• A Review of Concordance and Quality in Clinical Guidelines for Hormonal Contraceptives to Mitigate Drug–Drug Interactions in Women With Epilepsy
  di: Matthew R. Muschett, et al.
  Pubblicazione: (2024)
• Association of Pharmacist Interventions With Adverse Drug Events and Potential Adverse Drug Events
  di: W. N. Kelly, et al.
  Pubblicazione: (2024)
• Characteristics of United States Food and Drug Administration Drug Recalls Involving Opioid Medications, 2002–2025
  di: Julio C. Nunes, et al.
  Pubblicazione: (2026)
• Drug Safety: Being Vigilant… or Proactive?
  di: Alain Braillon
  Pubblicazione: (2026)